Oaktree Acquisition Corp. III Life Sciences - OACC
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G | Fort Baker Capital Management LP | 5.1% | 1,000,000 | View |
| May 15, 2026 | SCHEDULE 13G | Steven Patrick Pigott | 5.1% | 1,000,000 | View |
| May 15, 2026 | SCHEDULE 13G | Fort Baker Capital, LLC | 5.1% | 1,000,000 | View |
| May 11, 2026 | SCHEDULE 13G | THE GOLDMAN SACHS GROUP, INC. | 6.2% | 1,228,500 | View |
| May 11, 2026 | SCHEDULE 13G | GOLDMAN SACHS & CO. LLC | 6.2% | 1,228,500 | View |
| Feb 11, 2026 | SCHEDULE 13G/A | Barclays PLC | 4.35% | 861,625 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.